Restoration of dopamine release deficits during object recognition memory acquisition attenuates cognitive impairment in a triple transgenic mice model of Alzheimer's disease

Learning and Memory

Volumn 19, Issue 10, 2012, Pages 453-460

  Guzmán Ramos, Kioko ^a   Moreno Castilla, Perla ^a   Castro Cruz, Monica ^a   McGaugh, James L ^b   Martínez Coria, Hilda ^b   LaFerla, Frank M ^b   Bermúdez Rattoni, Federico ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; DOPAMINE; GLUTAMIC ACID; NOMIFENSINE; NORADRENALIN;

ALZHEIMER DISEASE; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE MODEL; DOPAMINE BRAIN LEVEL; DOPAMINE RELEASE; HIPPOCAMPUS; IN VIVO STUDY; INSULA; LONG TERM MEMORY; MALE; MEMORY CONSOLIDATION; MENTAL TEST; MICRODIALYSIS; MOUSE; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; SHORT TERM MEMORY; TRANSGENIC MOUSE; WILD TYPE;

AGE FACTORS; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BRAIN; COGNITION DISORDERS; DISEASE MODELS, ANIMAL; DOPAMINE; DOPAMINE UPTAKE INHIBITORS; EXPLORATORY BEHAVIOR; GLUTAMIC ACID; HUMANS; MALE; MEMORY DISORDERS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICRODIALYSIS; MUTATION; NOMIFENSINE; NOREPINEPHRINE; PHOTIC STIMULATION; PRESENILIN-1; RECOGNITION (PSYCHOLOGY); STATISTICS, NONPARAMETRIC; TAU PROTEINS;

EID: 84867641453     PISSN: 10720502     EISSN: 15495485     Source Type: Journal    
DOI: 10.1101/lm.026070.112     Document Type: Article

References (63)

1. Ambree O, Richter H, Sachser N, Lewejohann L, Dere E, de Souza Silva MA, Herring A, Keyvani K, Paulus W, Schabitz WR. 2009. Levodopa ameliorates learning and memory deficits in a murine model of Alzheimer's disease. Neurobiol Aging 30: 1192-1204.
2. Balderas I, Rodriguez-Ortiz CJ, Salgado-Tonda P, Chavez-Hurtado J, McGaugh JL, Bermudez-Rattoni F. 2008. The consolidation of object and context recognition memory involve different regions of the temporal lobe. Learn Mem 15: 618-624.
3. Barker GR, Bird F, Alexander V,Warburton EC. 2007. Recognition memory for objects, place, and temporal order: A disconnection analysis of the role of the medial prefrontal cortex and perirhinal cortex. J Neurosci 27: 2948-2957. (Pubitemid 46438982)
4. Bermudez-Rattoni F. 2004. Molecular mechanisms of taste-recognition memory. Nat Rev Neurosci 5: 209-217. (Pubitemid 38252477)
5. Bermudez-Rattoni F, Forthman DL, Sanchez MA, Perez JL, Garcia J. 1988. Odor and taste aversions conditioned in anesthetized rats. Behav Neurosci 102: 726-732.
6. Bermudez-Rattoni F, Introini-Collison IB, McGaugh JL. 1991. Reversible inactivation of the insular cortex by tetrodotoxin produces retrograde and anterograde amnesia for inhibitory avoidance and spatial learning. Proc Natl Acad Sci 88: 5379-5382. (Pubitemid 21914748)
7. Bermudez-Rattoni F, Ramirez-Lugo L, Gutierrez R, Miranda MI. 2004. Molecular signals into the insular cortex and amygdala during aversive gustatory memory formation. Cell Mol Neurobiol 24: 25-36. (Pubitemid 38233727)
8. Bermudez-Rattoni F, Okuda S, Roozendaal B, McGaugh JL. 2005. Insular cortex is involved in consolidation of object recognition memory. Learn Mem 12: 447-449. (Pubitemid 41397203)
9. Besheer J, Jensen HC, Bevins RA. 1999. Dopamine antagonism in a novel-object recognition and a novel-object place conditioning preparation with rats. Behav Brain Res 103: 35-44. (Pubitemid 29447701)
10. Besheer J, Short KR, Bevins RA. 2001. Dopaminergic and cholinergic antagonism in a novel-object detection task with rats. Behav Brain Res 126: 211-217. (Pubitemid 33009423)
11. Billings LM, Oddo S, Green KN, McGaugh JL, LaFerla FM. 2005. Intraneuronal Ab causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice. Neuron 45: 675-688. (Pubitemid 40320703)
12. Billings LM, Green KN, McGaugh JL, LaFerla FM. 2007. Learning decreases A b? 56 and tau pathology and ameliorates behavioral decline in 3xTg-AD mice. J Neurosci 27: 751-761. (Pubitemid 46174493)
13. Braak H, Braak E. 1991. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82: 239-259.
14. BrownMW, Aggleton JP. 2001. Recognition memory: What are the roles of the perirhinal cortex and hippocampus? Nat Rev Neurosci 2: 51-61. (Pubitemid 33673349)
15. Caccamo A, Fisher A, LaFerla FM. 2009. M1 agonists as a potential disease-modifying therapy for Alzheimer's disease. Curr Alzheimer Res 6: 112-117.
16. Chin J. 2011. Selecting a mouse model of Alzheimer's disease. Methods Mol Biol 670: 169-189.
17. Cracchiolo JR, Mori T, Nazian SJ, Tan J, Potter H, Arendash GW. 2007. Enhanced cognitive activity - over and above social or physical activity - is required to protect Alzheimer's mice against cognitive impairment, reduce Ab deposition, and increase synaptic immunoreactivity. Neurobiol Learn Mem 88: 277-294. (Pubitemid 47321221)
18. Davis KL, Mohs RC, Marin D, Purohit DP, Perl DP, Lantz M, Austin G, Haroutunian V. 1999. Cholinergic markers in elderly patients with early signs of Alzheimer disease. JAMA 281: 1401-1406. (Pubitemid 29190218)
19. Del Arco A, Mora F. 1999. Effects of endogenous glutamate on extracellular concentrations of GABA, dopamine, and dopamine metabolites in the prefrontal cortex of the freely moving rat: Involvement of NMDA and AMPA/KA receptors. Neurochem Res 24: 1027-1035. (Pubitemid 29406998)
20. De Leonibus E, Verheij MM, Mele A, Cools A. 2006. Distinct kinds of novelty processing differentially increase extracellular dopamine in different brain regions. Eur J Neurosci 23: 1332-1340.
21. de Lima MN, Presti-Torres J, Dornelles A, Siciliani Scalco F, Roesler R, Garcia VA, Schroder N. 2011. Modulatory influence of dopamine receptors on consolidation of object recognition memory. Neurobiol Learn Mem 95: 305-310.
22. Duva CA, Floresco SB,Wunderlich GR, Lao TL, Pinel JP, Phillips AG. 1997. Disruption of spatial but not object-recognition memory by neurotoxic lesionsofthedorsal hippocampusinrats. BehavNeurosci 111: 1184-1196. (Pubitemid 28010896)
23. Feenstra MG, Botterblom MH. 1996. Rapid sampling of extracellular dopamine in the rat prefrontal cortex during food consumption, handling and exposure to novelty. Brain Res 742: 17-24. (Pubitemid 27016003)
24. Galluzzi KE, Appelt DM, Balin BJ. 2010. Modern care for patients with Alzheimer disease: Rationale for early intervention. J Am Osteopath Assoc 110: S37-S42.
25. Girault JA, Greengard P. 2004. The neurobiology of dopamine signaling. Arch Neurol 61: 641-644. (Pubitemid 38637678)
26. Guzmán-Ramos K, Osorio-Gomez D, Moreno-Castilla P, Bermudez-Rattoni F. 2010. Off-line concomitant release of dopamine and glutamate involvement in taste memory consolidation. J Neurochem 114: 226-236.
27. Himeno E, Ohyagi Y, Ma L, Nakamura N, Miyoshi K, Sakae N, Motomura K, Soejima N, Yamasaki R, Hashimoto T, et al. 2010. Apomorphine treatment in Alzheimer mice promoting amyloid-β degradation. Ann Neurol 69: 248-256.
28. Jankowsky JL, Melnikova T, Fadale DJ, Xu GM, Slunt HH, Gonzales V, Younkin LH, Younkin SG, Borchelt DR, Savonenko AV. 2005. Environmental enrichment mitigates cognitive deficits in a mouse model of Alzheimer's disease. J Neurosci 25: 5217-5224. (Pubitemid 40726973)
29. Jay TM. 2003. Dopamine: A potential substrate for synaptic plasticity and memory mechanisms. Prog Neurobiol 69: 375-390. (Pubitemid 36859925)
30. Joyce JN, Kaeger C, Ryoo H, Goldsmith S. 1993. Dopamine D2 receptors in the hippocampus and amygdala in Alzheimer's disease. Neurosci Lett 154: 171-174. (Pubitemid 23172349)
31. Joyce JN, Myers AJ, Gurevich E. 1998. Dopamine D2 receptor bands in normal human temporal cortex are absent in Alzheimer's disease. Brain Res 784: 7-17. (Pubitemid 28137843)
32. Jurgensen S, Antonio LL, Mussi GE, Brito-Moreira J, Bomfim TR, De Felice FG, Garrido-Sanabria ER, Cavalheiro EA, Ferreira ST. 2010. Activation of D1/D5 dopamine receptors protects neurons from synapse dysfunction induced by amyloid-b oligomers. J Biol Chem 286: 3270-3276.
33. Kemppainen N, Laine M, Laakso MP, Kaasinen V, Nagren K, Vahlberg T, Kurki T, Rinne JO. 2003. Hippocampal dopamine D2 receptors correlate withmemoryfunctionsinAlzheimer'sdisease. Eur JNeurosci 18: 149-154.
34. Kumar U, Patel SC. 2007. Immunohistochemical localization of dopamine receptor subtypes (D1R-D5R) in Alzheimer's disease brain. Brain res 1131: 187-196. (Pubitemid 46053892)
35. LaFerla FM. 2010. Pathways linking Ab and tau pathologies. Biochem Soc Trans 38: 993-995.
36. LaFerla FM, Green KN, Oddo S. 2007. Intracellular amyloid-β in Alzheimer's disease. Nat Rev Neurosci 8: 499-509.
37. Martorana A, Mori F, Esposito Z, Kusayanagi H, Monteleone F, Codeca C, Sancesario G, Bernardi G, Koch G. 2009. Dopamine modulates cholinergic cortical excitability in Alzheimer's disease patients. Neuropsychopharmacology 34: 2323-2328.
38. Mastrangelo MA, Bowers WJ. 2008. Detailed immunohistochemical characterization of temporal and spatial progression of Alzheimer's disease-related pathologies in male triple-transgenic mice. BMC Neurosci 9: 81.
39. Nagai T, Takuma K, Kamei H, Ito Y, Nakamichi N, Ibi D, Nakanishi Y, Murai M, Mizoguchi H, Nabeshima T, et al. 2007. Dopamine D1 receptors regulate protein synthesis-dependent long-term recognition memory via extracellular signal-regulated kinase 1/2 in the prefrontal cortex. Learn Mem 14: 117-125. (Pubitemid 46495188)
40. Nazarali AJ, Reynolds GP. 1992. Monoamine neurotransmitters and their metabolites in brain regions in Alzheimer's disease: A postmortem study. Cell Mol Neurobiol 12: 581-587.
41. Nicholson RM, Kusne Y, Nowak LA, LaFerla FM, Reiman EM, Valla J. 2010. Regional cerebral glucose uptake in the 3xTG model of Alzheimer's disease highlights common regional vulnerability across AD mouse models. Brain Res 1347: 179-185.
42. Oddo S, Caccamo A, Kitazawa M, Tseng BP, LaFerla FM. 2003a. Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease. Neurobiol Aging 24: 1063-1070. (Pubitemid 37487883)
43. Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, Metherate R, Mattson MP, Akbari Y, LaFerla FM. 2003b. Triple-transgenic model of Alzheimer's disease with plaques and tangles: Intracellular Ab and synaptic dysfunction. Neuron 39: 409-421. (Pubitemid 36937044)
44. Oddo S, Billings L, Kesslak JP, Cribbs DH, LaFerla FM. 2004. Aβ immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome. Neuron 43: 321-332. (Pubitemid 39061125)
45. Paxinos G, Franklin K. 2007. The mouse brain in stereotaxic coordinates. Elsevier Academic Press, Amsterdam.
46. Pietropaolo S, Feldon J, Yee BK. 2008. Age-dependent phenotypic characteristics of a triple transgenic mouse model of Alzheimer disease. Behav Neurosci 122: 733-747.
47. Preda S, Govoni S, Lanni C, Racchi M, Mura E, Grilli M, Marchi M. 2008. Acute b-amyloid administration disrupts the cholinergic control of dopamine release in the nucleus accumbens. Neuropsychopharmacology 33: 1062-1070. (Pubitemid 351367542)
48. Querfurth HW, LaFerla FM. 2010. Alzheimer's disease. N Engl J Med 362: 329-344.
49. Roozendaal B, Castello NA, Vedana G, Barsegyan A, McGaugh JL. 2008. Noradrenergic activation of the basolateral amygdala modulates consolidation of object recognition memory. Neurobiol Learn Mem 90: 576-579.
50. Rossato JI, Bevilaqua LR, Izquierdo I, Medina JH, Cammarota M. 2009. Dopamine controls persistence of long-term memory storage. Science 325: 1017-1020.
51. Rothblat LA, Kromer LF. 1991. Object recognition memory in the rat: The role of the hippocampus. Behav Brain Res 42: 25-32.
52. Rudbeck L, Dissing J. 1998. Rapid, simple alkaline extraction of human genomic DNA from whole blood, buccal epithelial cells, semen and forensic stains for PCR. BioTechniques 25: 588-592. (Pubitemid 28465687)
53. Sarter M, Bruno JP, Parikh V. 2007. Abnormal neurotransmitter release underlying behavioral and cognitive disorders: Toward concepts of dynamic and function-specific dysregulation. Neuropsychopharmacology 32: 1452-1461. (Pubitemid 46920162)
54. Schultz W. 2007. Behavioral dopamine signals. Trends Neurosci 30: 203-210. (Pubitemid 46654238)
55. Selkoe DJ. 2001. Alzheimer's disease: Genes, proteins, and therapy. Physiol Rev 81: 741-766. (Pubitemid 32267077)
56. Shearman E, Rossi S, Szasz B, Juranyi Z, Fallon S, Pomara N, Sershen H, Lajtha A. 2006. Changes in cerebral neurotransmitters and metabolites induced by acute donepezil and memantine administrations: A microdialysis study. Brain Res Bull 69: 204-213. (Pubitemid 43375876)
57. Smith JA, Knight RG. 2002. Memory processing in Alzheimer's disease. Neuropsychologia 40: 666-682. (Pubitemid 34037049)
58. Storga D, Vrecko K, Birkmayer JG, Reibnegger G. 1996. Monoaminergic neurotransmitters, their precursors and metabolites in brains of Alzheimer patients. Neurosci Lett 203: 29-32. (Pubitemid 26029841)
59. Stupien G, Florian C, Roullet P. 2003. Involvement of the hippocampal CA3-region in acquisition and in memory consolidation of spatial but not in object information in mice. Neurobiol Learn Mem 80: 32-41. (Pubitemid 36539436)
60. Ungless MA. 2004. Dopamine: The salient issue. Trends Neurosci 27: 702-706. (Pubitemid 39488072)
61. Viggiano MP, Galli G, Righi S, Brancati C, Gori G, Cincotta M. 2008. Visual recognition memory in Alzheimer's disease: Repetition-lag effects. Exp Aging Res 34: 267-281. (Pubitemid 351882838)
62. Winblad B, Hardy J, Backman L, Nilsson LG. 1985. Memory function and brain biochemistry in normal aging and in senile dementia. Ann N Y Acad Sci 444: 255-268. (Pubitemid 15237835)
63. Zhu XO, McCabe BJ, Aggleton JP, BrownMW. 1997. Differential activation of the rat hippocampus and perirhinal cortex by novel visual stimuli and a novel environment. Neurosci Lett 229: 141-143. (Pubitemid 27306841)